NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aztreonam | AZTREONAM | Hospira, Inc. | d4500795-3b07-4a7d-b432-73cafbb3dbc6 | 2024-06-03 | Warnings, Adverse reactions | Hospira, Inc. |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | ed1b74a8-2a9b-4315-b051-673c7941cb13 | 2024-05-14 | Warnings, Adverse reactions | Hospira, Inc. |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Hospira, Inc. | e5054c6a-c54e-4ddf-8280-a154b90cac07 | 2024-04-15 | Adverse reactions | Hospira, Inc. |
| Bortezomib | BORTEZOMIB | Hospira, Inc. | 41e3de39-8278-4a75-badf-601e4602080d | 2024-04-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Diazepam | DIAZEPAM | Hospira, Inc. | 41044928-dd1f-40bf-1fa6-709dff559124 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Atracurium Besylate | ATRACURIUM BESYLATE | Hospira, Inc. | de1c2dcd-295b-47ce-b7a1-a8be59939a54 | 2023-11-23 | Warnings, Adverse reactions | Hospira, Inc. |
| rocuronium bromide | ROCURONIUM BROMIDE | Hospira, Inc. | f01f9986-43f9-40e8-9506-11bfe78f9242 | 2023-08-29 | Warnings, Adverse reactions | Hospira, Inc. |
| rocuronium bromide | ROCURONIUM BROMIDE | Hospira, Inc. | c96726ef-f1fa-4ebb-ba33-3479c3902a8e | 2023-06-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | b598c237-032d-4bb5-0e92-50eabd863dac | 2023-06-04 | Warnings, Adverse reactions | Hospira, Inc. |
| BORTEZOMIB | BORTEZOMIB | Hospira, Inc. | 9fdf6169-699f-40eb-bda1-760253062b3c | 2023-02-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Bleomycin | BLEOMYCIN | Hospira, Inc. | 905e0984-2ce3-481c-b1a0-0ef0a616479a | 2022-08-25 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Bleomycin | BLEOMYCIN | Hospira, Inc. | e629ba5a-4e08-4249-9551-af6dbd98a7e4 | 2022-08-25 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Milrinone Lactate in Dextrose | MILRINONE LACTATE IN DEXTROSE | Hospira, Inc. | 5273ea17-6920-4bff-8c5b-20ea531a0423 | 2022-03-28 | Warnings, Adverse reactions | Hospira, Inc. |
| BUSULFAN | BUSULFAN | Hospira, Inc. | b9c7f0dc-988d-466e-8031-400ec4f60f21 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Hospira, Inc. | d3579d45-a964-40fe-e3a2-a3a997c8b7b9 | 2021-05-28 | Warnings, Adverse reactions | Hospira, Inc. |
| Topotecan | TOPOTECAN | Hospira, Inc. | 1d4e1cce-c57e-4a8b-be96-f95a2778e221 | 2021-02-01 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.